GlobeNewswire

PharmaTher Receives US FDA Approval Goal Date for Ketamine

PharmaTher Receives US FDA Approval Goal Date for Ketamine

March 11, 2025

The Assigned FDA Approval Goal Date is June 4, 2025 TORONTO, March 11, 2025 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd....

Read More

Minoryx doses first patient with leriglitazone in Rett syndrome study

Minoryx doses first patient with leriglitazone in Rett syndrome study

March 12, 2025

Orphelia Pharma explores other pathways for paediatric cancer treatment

Orphelia Pharma explores other pathways for paediatric cancer treatment

March 12, 2025

USDA, HHS Share Update on Dietary Guidelines for Americans Process

USDA, HHS Share Update on Dietary Guidelines for Americans Process

March 11, 2025

USDA Status Update on Probationary Employees

USDA Status Update on Probationary Employees

March 11, 2025

Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests

Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests

March 11, 2025